Zyn is not FDA approved, but it is FDA authorized, and that distinction matters. In January 2025, the FDA issued marketing granted orders for 20 Zyn nicotine pouch products, allowing them to be legally sold in the United States to adults 21 and older. The FDA itself has been explicit on this point: authorization to market a tobacco product is not the same as FDA approval, and it does not mean the products are safe.
Authorized vs. Approved: Why the Difference Matters
FDA approval is a term reserved for drugs, medical devices, and certain other regulated products. It means the agency has determined something is safe and effective for its intended use. Tobacco products can never receive FDA approval because, in the agency’s words, “all tobacco products are harmful and potentially addictive.”
What Zyn received is a marketing granted order through the premarket tobacco product application (PMTA) pathway. This means the FDA reviewed extensive scientific evidence and concluded that allowing these specific products on the market is “appropriate for the protection of public health.” That’s a lower bar than calling something safe. It weighs factors like whether the product might pull adult smokers away from more harmful options against the risk of attracting new nicotine users, particularly young people.
Which Zyn Products Are Authorized
The FDA authorized 20 specific products: 10 flavors, each in two nicotine strengths (3 milligram and 6 milligram). The authorized flavors are Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen.
Any Zyn product not on that list is not authorized. In fact, before the January 2025 decision, the FDA issued warning letters to three online retailers for selling unauthorized flavored Zyn varieties, including Espressino, Black Cherry, Lemon Spritz, and Cucumber Lime. If you see a Zyn flavor that isn’t one of those 10, it hasn’t gone through the FDA’s review process.
How Long the Review Took
The authorization was years in the making. Swedish Match, the company behind Zyn (now owned by Philip Morris International), submitted its applications and began responding to FDA deficiency letters as early as August 2020. Over the next several years, the company filed multiple amendments addressing everything from scientific data updates to whether the phrase “tobacco-free” could appear on packaging. The final updates to labeling and scientific literature were submitted in December 2023, and the marketing granted order came through on January 16, 2025.
As recently as April 2024, the FDA had not yet authorized any Zyn product, which means for most of the time Zyn was widely available in stores, it was technically on the market without formal authorization. This is common with tobacco products that submitted PMTAs on time and were allowed to remain on shelves while the FDA processed a massive backlog of applications.
Underage Sales and Enforcement
Even with authorization, the FDA has been aggressive about enforcement around youth access. In April 2024, the agency issued 119 warning letters and filed 41 civil money penalty complaints against brick-and-mortar retailers that sold Zyn to minors between October 2023 and February 2024. The penalties sought totaled more than $55,000. These actions signal that while the products can be legally sold, retailers face real consequences for selling them to anyone under 21.
Safety Risks the FDA Has Flagged
The authorization doesn’t come with a clean bill of health. The FDA has raised specific concerns about accidental exposure, particularly among children and pets. Between April 2022 and March 2025, reports of nicotine pouch exposures to U.S. Poison Centers steadily increased. Roughly 72% of those cases involved children under 5, and nearly all (99%) involved ingestion, meaning kids were eating or chewing on the pouches.
Nicotine poisoning in young children can cause confusion, vomiting, and loss of consciousness. In severe cases, it can lead to trouble breathing or seizures. The FDA recommends storing nicotine pouches where children and pets cannot reach them.
How Synthetic Nicotine Fits In
Zyn pouches contain nicotine that is either chemically synthesized or derived from tobacco leaf, and for a time, products using synthetic nicotine fell into a regulatory gray area. That changed in March 2022, when Congress passed a law clarifying that the FDA has authority over tobacco products containing nicotine from any source, including lab-made nicotine. The provision took effect on April 14, 2022, closing the loophole that some nicotine pouch and vape companies had tried to exploit.
This means every nicotine pouch on the U.S. market, regardless of where the nicotine comes from, falls under the FDA’s tobacco product authority and needs a marketing granted order to be sold legally.